OMER News and Press, Omeros Corporation From 11/30/18

NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Omeros Corporation (NASDAQ:OMER), Apple Inc. (NASDAQ:AAPL), Bio-Rad La...

Omeros Corporation (NASDAQ: OMER) today announced that the company will issue its third quarter 2018 financial results for the period ended September 30, 2018, on Friday, November 9, 2018, before the market opens. Omeros management will host a conference call and webcast that day at 8:30 a.m...

The FDA grants Orphan Drug status for Omeros' ( OMER +8.9% ) lead candidate OMS721 for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA), a severe complication of HSCT characterized by blood clotting in the smallest blood vessels in the ...

-- OMS721 now with orphan designation covering both prevention and treatment of HSCT-TMA in U.S. and in Europe -- Omeros Corporation (NASDAQ:OMER) today announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment ...

NEW YORK, Oct. 23, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Hecla Mining Company (NYSE:HL), Atlas Air Worldwide Holdings (NASDAQ:AAWW...

Welcome to the Daily Pharma Scoop, a daily feature from the creators of the Total Pharma Tracker, a popular biopharma Marketplace service here on Seeking Alpha. In the daily scoop, we focus in on one key investment concept from the biopharma space and also provide quick commentary on other imp...

DTEA +39%  on speculative move . More news on: DAVIDs TEA, Cellectar Biosciences, Inc., Oragenics, Inc., Stocks on the move, , Top stock market news, Read more ...

NEW YORK, NY / ACCESSWIRE / October 2, 2018 / U.S. equities were mixed on Monday after the U.S. and Canada agreed to revise the current North American Free Trade Agreement. The Dow Jones Industrial Average gained 0.73 percent to close at 26,651.21, while the S&P 500 Index closed 0.36 pe...

Top Gainers:   IGC   +11.4% . OMER +9.9% . DTEA +9.4% . SENS +4.6% . SYN   +3.9% . More news on: India Globalization Capital, Inc, Omeros Corporation, DAVIDs TEA, Stocks on the move, , News on ETFs, Top stock market news, Read more ...

Omeros ( OMER -5.3% ) announces positive results from a Phase 2 clinical trial evaluating OMS721 in corticosteroid therapy-naive patients with immunoglobulin A (IgA) nephropathy. More news on: Omeros Corporation, Healthcare stocks news, Stocks on the move, Read more ...